CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/04/2022
Voltar para busca
Dado oficial do USPTO
NEUWAY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NEUWAY
ST13
US500000088278750Classe
1, 5, 40, 42
Pedido
88278750
Registro
6466029
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
26/04/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 40, 42
Data de depósito
28/01/2019
Data de registro
31/08/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/08/2021
Última transação
31/08/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Bonn, DE
Examinador
MIZELLE HOWARD, DEZMONA JULYE
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NEUWAY Pharma GmbH
Representantes
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiologicalbiochemical and biotechnological products and preparationsnamely small moleculesbiologicsnucleic acidsproteinslipidspolysaccharidesenzymesantibodiescellsmicroorganisms as well as fragmentsfractions and derivatives thereof for laboratory or research use and manufacturing use
Classe 5
Chemicalbiologicalbiochemical and biotechnological products and preparations for medicalveterinary and pharmaceutical purposesfor the prevention and treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunction and pain as well as for gene therapyvaccination or immunostimmulationnamely small moleculesbiologicsnucleic acidsproteinslipidspolysaccharidesenzymesantibodiescellsmicroorganisms as well as fragmentsfractions and derivatives thereof; diagnostic preparations for medical and veterinary use; medicinal preparationspharmaceutical preparations and pharmaceutical substances for the prevention and treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunction and pain as well as for gene therapyvaccination or immunostimmulation; vaccines; adjuvantscarriers for active ingredientsdrug delivery systems comprising protein based capsids or particles for the release of therapeutic or diagnostic agents for medical use in humans or animals; biological implants comprising active ingredients; drug delivery systems consisting of proteins in the form of capsids or particles; drug delivery systems comprising protein based capsids or particles for the release of therapeutic or diagnostic agents
Classe 40
Manufacture of pharmaceutical productsmedicinal productsmedicaments from pharmaceutical compositions for third parties
Classe 42
Scientific research and development for othersin particular in the fields of medicinepharmacydiagnosticschemistrybiologybiochemistry and biotechnology; scientific research and development as well as biotechnological services with regard to manufacturing pharmaceutical preparationsactive substance carriersactive substance transport systemsdrug delivery systems and active substance implants for use on humans or animalsfor others; development of pharmaceutical preparationsmedical products for the prevention and treatment of neurologicalneurodegenerativepsychiatricimmune system relatedmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryurologicalgynecologicalreproductiveoncologicalhepatologicalophthalmicrespiratorygastrointestinalhormonaldermatologicallymphaticinflammatoryinfectioushematologicalrenalgeneticbacterial and viral diseasessexual dysfunction and pain as well as for gene therapyvaccination or immunostimmulationfor others
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/04/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/04/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/04/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
31/08/2021
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
27/07/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
22/07/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
01/07/2021
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
01/07/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
27/04/2021
PUBO
PUBLISHED FOR OPPOSITION
27/04/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/04/2021
OTHE
CASE RETURNED TO EXAMINATION
18/03/2021
IUCN
NOTICE OF ALLOWANCE CANCELLED
18/03/2021
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
30/10/2020
APET
ASSIGNED TO PETITION STAFF
29/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26/09/2020
EX2G
SOU EXTENSION 2 GRANTED
24/09/2020
EXT2
SOU EXTENSION 2 FILED
24/09/2020
EEXT
SOU TEAS EXTENSION RECEIVED
24/09/2020
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
11/09/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/03/2020
EX1G
SOU EXTENSION 1 GRANTED
23/03/2020
EXT1
SOU EXTENSION 1 FILED
23/03/2020
EEXT
SOU TEAS EXTENSION RECEIVED
23/03/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/03/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
20/03/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
20/03/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/03/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/03/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/03/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24/09/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/07/2019
PUBO
PUBLISHED FOR OPPOSITION
30/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/06/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/04/2019
GNRT
NON-FINAL ACTION E-MAILED
12/04/2019
CNRT
NON-FINAL ACTION WRITTEN
12/04/2019
DOCK
ASSIGNED TO EXAMINER
09/04/2019
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
25/02/2019
ALIE
ASSIGNED TO LIE
21/02/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/02/2019
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
14/02/2019
NWAP
NEW APPLICATION ENTERED
31/01/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEUWAY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.